Evidence map›Paper›PMID 28191736›Full record

ArticleCNS neuroscience & therapeutics2017

The phosphoinositide-3 kinase signaling is involved in neuroinflammation in hypertensive rats.

Xing Tan, Pei-Lei Jiao, Yang-Kai Wang, Zhao-Tang Wu, Xiao-Rong Zeng, Miao-Ling Li, Wei-Zhong Wang

Abstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Regulation Effect ofMediators of inflammation · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xing TanDepartment of Physiology and Center of Polar Medical Research, Second Military Medical University, Shanghai, China.
Pei-Lei JiaoDepartment of Physiology and Center of Polar Medical Research, Second Military Medical University, Shanghai, China.
Yang-Kai WangDepartment of Physiology and Center of Polar Medical Research, Second Military Medical University, Shanghai, China.
Zhao-Tang WuDepartment of Physiology and Center of Polar Medical Research, Second Military Medical University, Shanghai, China.
Xiao-Rong ZengInstitute of Cardiovascular Medical Research, West-South Medical University, Luzhou, China.
Miao-Ling LiInstitute of Cardiovascular Medical Research, West-South Medical University, Luzhou, China.
Wei-Zhong WangDepartment of Physiology and Center of Polar Medical Research, Second Military Medical University, Shanghai, China.ORCID http://orcid.org/0000-0001-6979-4505
Second Military Medical University · CNWest China Medical Center of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsIt has been demonstrated that neuroinflammation is associated with cardiovascular dysfunction. The phosphoinositide-3 kinase (PI3K) signaling in the rostral ventrolateral medulla (RVLM), a key region for sympathetic outflow, is upregulated and contributes to increased blood pressure (BP) and sympathetic outflow in hypertension. This study was designed to determine the role of the PI3K signaling in neuroinflammation in the RVLM of hypertension.

methodsThe normotensive WKY rats were performed by intracisternal infusion of lipopolysaccharide (LPS) or angiotensin II (Ang II) for inducing neuroinflammation. Elisa was used to determine the level of proinflammatory cytokines. Western blot was employed to detect the protein expression of PI3K signaling pathway. Gene silencing of PI3K p110δ subunit and overexpression of angiotensin-converting enzyme 2 (ACE2) were realized by injecting related lentivirus into the RVLM.

resultsIn the spontaneously hypertensive rats (SHR), the PI3K signaling in the RVLM was upregulated compared with WKY, gene silencing of PI3K in the RVLM significantly reduced BP and renal sympathetic nerve activity (RSNA), but also decreased the levels of proinflammatory cytokines. In the WKY rats, central infusion of LPS and Ang II significantly elevated BP and RSNA, but also increased the levels of proinflammatory cytokines and PI3K signaling activation in the RVLM. These changes in the Ang II-induced hypertension were effectively prevented by gene silencing of PI3K in the RVLM. Furthermore, overexpression of ACE2 in the RVLM significantly attenuated high BP and neuroinflammation, as well as decreased the activation of PI3K signaling in hypertensive rats.

conclusionThis study suggests that the PI3K signaling in the RVLM is involved in neuroinflammation in hypertension and plays an important role in the renin-angiotensin system-mediated changes in neuroinflammation in the RVLM.

Indexed as

Angiotensin-Converting Enzyme 2Angiotensin IIAnimalsBlood PressureCytokinesDose-Response Relationship, DrugEncephalitisHeart RateHumansHypertensionLipopolysaccharidesMaleMedulla OblongataPeptidyl-Dipeptidase APhosphatidylinositol 3-KinasesRatsACE2 protein, humanAce2 protein, ratAngiotensin-Converting Enzyme 2Angiotensin IICytokinesLipopolysaccharidesPeptidyl-Dipeptidase APhosphatidylinositol 3-KinasesRNA, Small InterferingACE2HypertensionneuroinflammationPI3K signalingRVLM

Identifiers

PMID28191736
PMCPMC6492662
OpenAlexW2586119714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.